These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 29693121
1. microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma. Lai Y, Zhao L, Hu J, Quan J, Chen P, Xu J, Guan X, Lai Y, Ni L. Mol Med Rep; 2018 Jun; 17(6):8510-8517. PubMed ID: 29693121 [Abstract] [Full Text] [Related]
2. Identification of miR‑30b as an oncogene in renal cell carcinoma. Jin L, Li Y, He T, Hu J, Liu J, Chen M, Shi M, Jiang Z, Yang S, Mao X, Gui Y, Lai Y. Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953 [Abstract] [Full Text] [Related]
3. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis. Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y. Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244 [Abstract] [Full Text] [Related]
4. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Li Y, Chen D, Jin L, Liu J, Su Z, Li Y, Gui Y, Lai Y. Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577 [Abstract] [Full Text] [Related]
5. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma. Jin L, Li Y, Nie L, He T, Hu J, Liu J, Chen M, Shi M, Jiang Z, Gui Y, Yang S, Lai Y. Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105 [Abstract] [Full Text] [Related]
6. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis. Pan X, Li Z, Zhao L, Quan J, Zhou L, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Lai Y. Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566 [Abstract] [Full Text] [Related]
7. miR‑15a‑5p acts as an oncogene in renal cell carcinoma. Jin L, Li Y, He T, Hu J, Liu J, Chen M, Zhang Z, Gui Y, Mao X, Yang S, Lai Y. Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906 [Abstract] [Full Text] [Related]
8. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. Li Y, Guan B, Liu J, Zhang Z, He S, Zhan Y, Su B, Han H, Zhang X, Wang B, Li X, Zhou L, Zhao W. EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475 [Abstract] [Full Text] [Related]
9. Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma. Chen P, Lin C, Quan J, Lai Y, He T, Zhou L, Pan X, Wu X, Wang Y, Ni L, Yang S, Wang T, Lai Y. Mol Med Rep; 2017 Oct; 16(4):5023-5030. PubMed ID: 28765937 [Abstract] [Full Text] [Related]
10. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H. Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839 [Abstract] [Full Text] [Related]
11. MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma. Zhao L, Quan J, Li Z, Pan X, Wang J, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Chen Y, Lai Y. Int J Mol Med; 2019 Jan; 43(1):525-534. PubMed ID: 30320376 [Abstract] [Full Text] [Related]
12. miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma. Sun C, Sun C, Zhou Y, Yang G, Li G, Xiang C, Ding X, Sun J. Mol Med Rep; 2019 Dec; 20(6):5208-5215. PubMed ID: 31661131 [Abstract] [Full Text] [Related]
13. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X, Yu JJ. Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [Abstract] [Full Text] [Related]
14. Identification of miR‑195‑3p as an oncogene in RCC. Jin L, Li X, Li Y, Zhang Z, He T, Hu J, Liu J, Chen M, Shi M, Jiang Z, Gui Y, Yang S, Mao X, Lai Y. Mol Med Rep; 2017 Apr; 15(4):1916-1924. PubMed ID: 28260025 [Abstract] [Full Text] [Related]
15. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma. Jin L, Fu H, Quan J, Pan X, He T, Hu J, Li Y, Li H, Yang Y, Ye J, Zhang F, Ni L, Yang S, Lai Y. Mol Med Rep; 2017 Oct; 16(4):4463-4468. PubMed ID: 28765964 [Abstract] [Full Text] [Related]
16. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells. Wang X, Lu Y, Tuo Z, Zhou H, Zhang Y, Cao Z, Peng L, Yu D, Bi L. Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836 [Abstract] [Full Text] [Related]
17. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2. Ye ZH, Gui DW. Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648 [Abstract] [Full Text] [Related]
18. Oncogenic miR-23a-5p is associated with cellular function in RCC. Quan J, Jin L, Pan X, He T, Lai Y, Chen P, Lin C, Yang S, Zeng H, Lai Y. Mol Med Rep; 2017 Aug; 16(2):2309-2317. PubMed ID: 28656260 [Abstract] [Full Text] [Related]
19. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. Lu R, Ji Z, Li X, Zhai Q, Zhao C, Jiang Z, Zhang S, Nie L, Yu Z. J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875 [Abstract] [Full Text] [Related]
20. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Lin C, Li Z, Chen P, Quan J, Pan X, Zhao L, Zhou L, Lai Y, He T, Xu W, Xu J, Guan X, Li H, Yang S, Hu Y, Lai Y. Life Sci; 2018 Sep 15; 209():481-489. PubMed ID: 30138594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]